Item 4 — Purpose of Transaction
Item 4 of the Original Schedule 13D is hereby amended and supplemented as follows: Credit Agreement On April 27, 2026, Oxus Capital entered into the Credit Agreement with the Borrowers and the Guarantors. The Credit Agreement provides for a credit facility in the aggregate principal amount of up to $17 million and is intended to provide working capital support to the Borrowers. The Credit Agreement contains customary covenants and events of default. Conversion Agreement On April 27, 2026, Oxus Capital, together with Z Ventures and Zargos (together with Oxus Capital, the "Shareholders"), entered into the Conversion Agreement with the Company and the Guarantors. Pursuant to the Conversion Agreement, on or before July 1, 2026 (the "Equity Raise Deadline"), if the Company has not consummated one or more equity financings resulting in gross proceeds of at least $70,000,000 at a per share price of $9.00 per share (the "Required Equity Financing"), then, automatically and without further action by the parties, the entire amount of the Indebtedness owed to each Shareholder will convert into shares of the Company (the "Automatic Conversion"). The obligations arising under the Credit Agreement are expressly excluded from the Indebtedness subject to the Automatic Conversion. The conversion price is equal to Fair Market Value (as defined in the Conversion Agreement). The exact number of Common Shares issuable upon the Automatic Conversion cannot be determined as of the date of this filing because the Fair Market Value has not yet been determined. The right to acquire Common Shares upon conversion of the Indebtedness represents a plan or proposal relating to the acquisition of additional securities of the Issuer within the meaning of Item 4 of Schedule 13D. The Reporting Persons entered into the Conversion Agreement in connection with a broader financing arrangement and as part of their ongoing investment in and support of the Issuer's business operations. Subject to the agreements described herein, the Reporting Persons, at any time and from time to time, may review, reconsider and change their position and/or change their purpose and/or develop such plans and may seek to influence management or the board of directors of the Issuer with respect to the business and affairs of the Issuer and may from time to time consider pursuing or proposing such matters with advisors, the Issuer or other persons.